The Sedona Conference WG9/WG10 Patent Litigation Working Groups 2017 Annual Meeting

The Sedona Conference WG9/WG10 Patent Litigation Working Groups 2017 Annual Meeting

Speaking Engagement

WG9 and WG10 has several ongoing and newly launched Commentary drafting projects in process, including on:

  • WG10 Chapter on Parallel USPTO Proceedings ("Stage Two" - from the perspective of USPTO Patent and Trial Appeal Board (PTAB) litigation)
  • WG10 Chapter on Multi-District Litigation and "Pseudo-MDLs"
  • WG10 Section on Willful Infringement in light of Halo Electronics
  • WG10 Chapter on International Trade Commission Section 337 Patent Litigation
  • WG10 Chapter on Biopharma Litigation
  • WG9 Commentary on Case Management of Patent Damages and Remedies Issues
  • WG9 Section on Patent Damages Hearings
  • WG9 Commentary on Standard-Essential Patents and FRAND Issues

Join the dialogue to bring these commentaries, with their principles and best practice recommendations for a better patent system, toward true non-partisan, consensus-based publication in the true Sedona fashion.

WilmerHale Partner Andrea Weiss Jeffries will speak on the trade secrets panel and will moderate the panel "Whether damages-focused hearings can be used relatively early in the case to focus the litigation" and WilmerHale Partner Mark Selwyn will speak on the panel "FRAND and SEP - Effective case management to focus the issues and advance the litigation."

Read More About the Event

Speakers

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.